BILL · 2017–18 SESSION

SB 5839: Rx drug warehousing firms

Repealing a tax preference for prescription drug warehousing firms to invest in rural and high-need area opioid use disorder treatment and support infrastructures.

Summary

  • Creates the Opioid Use Disorder Treatment Account to fund grants to programs that increase access to medication-assisted treatment.
  • Repeals the tax preference for warehousing and selling prescription drugs.
  • Requires the Secretary of the Department of Health to distribute grants funded by increased revenue from the repeal of this tax preference.

From the Senate Bill Report (SB 5839), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedFeb 16, 2017
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Senator (D-36)
Introduced
February 16, 2017 in the Senate
Last action
January 11, 2018
Budget
Has a fiscal note

AN ACT Relating to repealing a tax preference for prescription drug warehousing firms to invest in rural and high-need area opioid use disorder treatment and support infrastructures;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. Referred to Health & Long Term Care.
  2. And refer to Health & Long Term Care.
  3. HSC - Majority; without recommendation.
  4. Due to Senate committee reorganization, referred to Human Services & Corrections.
  5. By resolution, reintroduced and retained in present status.
  6. By resolution, reintroduced and retained in present status.
  7. By resolution, reintroduced and retained in present status.
  8. By resolution, reintroduced and retained in present status.
  9. First reading, referred to Human Services, Mental Health & Housing.

SB 5839 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page